Department of Oral and Maxillofacial Surgery, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Department of Anesthesiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Arch Oral Biol. 2020 Feb;110:104587. doi: 10.1016/j.archoralbio.2019.104587. Epub 2019 Nov 8.
To provide a prognostic biomarker and a potential therapeutic target for tongue squamous cell carcinoma (TSCC).
Screening the prognostic genes of TSCC by bioinformatics, and verifying the correlation between the above genes and the prognosis of TSCC by experiments.
Twenty-four common differentially expressed genes (DEGs) between TSCC and the corresponding normal tissues were screened from four sets of TSCC functional gene expression series in Gene Expression Omnibus (GEO) datasets. Further bioinformatics research based on the data from The Cancer Genome Atlas (TCGA), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) indicate that the low expression of SFRP1 might be correlated with poor prognosis of TSCC patients. By colony formation assay, reverse transcription polymerase chain reaction (RT-PCR), western blotting, immunohistochemical staining, flowcytometry, lentivirus transfection and animal experiments, it was confirmed that the low level of SFRP1 expression correlated with poor prognosis of TSCC patients.
This study identified SFRP1 as a novel prognostic biomarker and a potential therapeutic target for TSCC.
为舌鳞状细胞癌(TSCC)提供一个预后生物标志物和潜在的治疗靶点。
通过生物信息学筛选 TSCC 的预后基因,并通过实验验证上述基因与 TSCC 预后的相关性。
从四个 GEO 数据集的 TSCC 功能基因表达系列中筛选出 24 个 TSCC 与相应正常组织之间的常见差异表达基因(DEG)。进一步基于 TCGA、GO、KEGG 数据的生物信息学研究表明,SFRP1 的低表达可能与 TSCC 患者的不良预后相关。通过集落形成实验、逆转录聚合酶链反应(RT-PCR)、Western blot、免疫组织化学染色、流式细胞术、慢病毒转染和动物实验,证实 SFRP1 的低表达与 TSCC 患者的不良预后相关。
本研究鉴定了 SFRP1 作为 TSCC 的一个新的预后生物标志物和潜在的治疗靶点。